Biomedical Research
Renata Medical Receives FDA Approval for the Minima Growth Stent
August 29, 2024
We are thrilled to share that Renata Medical, a growth stent company developing cardiovascular devices for unmet pediatric needs, has received FDA-approval for their first product, the Minima Growth Stent.
The Minima Growth Stent is a first-of-its-kind device, tailored for infants and young children, and designed to grow with the child – an enormous advancement that will transform care for neonates, infants, and young children with aortic or pulmonary stenosis.
We’re incredibly proud to support Renata Medical and the development of the Minima Stent System. This groundbreaking advancement in the field of pediatric congenital heart disease will transform the way single ventricle patients are treated and move us toward improved outcomes.